BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35240961)

  • 1. Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT.
    Özkul B; Özkul Ö; Bilir C
    Curr Med Imaging; 2022; 18(10):1079-1085. PubMed ID: 35240961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
    Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
    Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
    Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
    Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management.
    Jalal M; Campbell JA; Wadsley J; Hopper AD
    J Gastrointest Cancer; 2021 Sep; 52(3):1183-1187. PubMed ID: 34292498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
    Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
    BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Smee R; Moses D; Bauer J
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
    PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
    Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
    J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
    Mallet R; Modzelewski R; Lequesne J; Mihailescu S; Decazes P; Auvray H; Benyoucef A; Di Fiore F; Vera P; Dubray B; Thureau S
    Radiat Oncol; 2020 May; 15(1):116. PubMed ID: 32443967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study.
    Liu S; Han X; Li J; Xie X; Yang Y; Jiang W; Liu L; Liu Z
    PeerJ; 2023; 11():e16652. PubMed ID: 38099314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis.
    Xu Z; Yang D; Luo J; Xu H; Jia J; Yang Z
    J Magn Reson Imaging; 2023 Nov; 58(5):1569-1578. PubMed ID: 36932680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
    PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging-based diagnosis of sarcopenia for transplant-free survival in primary sclerosing cholangitis.
    Keshoofi P; Schindler P; Rennebaum F; Cordes F; Morgul H; Wildgruber M; Heinzow HS; Pascher A; Schmidt HH; Hüsing-Kabar A; Praktiknjo M; Trebicka J; Seifert LL
    BMC Gastroenterol; 2024 Apr; 24(1):145. PubMed ID: 38664624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.
    Nakamura N; Hara T; Shibata Y; Matsumoto T; Nakamura H; Ninomiya S; Kito Y; Kitagawa J; Kanemura N; Goto N; Shiraki M; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
    Ann Hematol; 2015 Dec; 94(12):2043-53. PubMed ID: 26385388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.